or Try an Advanced Search...

    Technical Analysis for GOSS - Gossamer Bio, Inc.

    Grade Last Price % Change Price Change
    F 0.70 -2.56% -0.02
    GOSS closed down 2.56 percent on Wednesday, November 20, 2024, on 1.14 times normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical GOSS trend table...
    Date Alert Name Type % Chg
    Lower Bollinger Band Walk Weakness 0.00%
    Wide Bands Range Expansion 0.00%
    Below Lower BB Weakness 0.00%
    Down 3 Days in a Row Weakness 0.00%
    Down 4 Days in a Row Weakness 0.00%
    Down 5 Days in a Row Weakness 0.00%
    Lower Bollinger Band Touch Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    Lower Bollinger Band Walk Weakness -2.56%
    Wide Bands Range Expansion -2.56%
    Older End-of-Day Signals for GOSS ...

       Recent Intraday Alerts

    Alert Time
    Fell Below Previous Day's Low about 19 hours ago
    60 Minute Opening Range Breakdown about 20 hours ago
    1.5x Volume Pace about 21 hours ago
    Down 3% about 21 hours ago
    Down 2 % about 22 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    GOSS Chart by TradingView
    Basic chart:

    Profile

    Gossamer Bio is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology. Its goal is to be an industry leader in each of these therapeutic areas and to enhance and extend the lives of patients suffering from such diseases.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Life Sciences Disease Immunology Inflammation Millennium Pharmaceuticals

    Is GOSS a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 15 After Plunging -20% in 4 Weeks, Here's Why the Trend Might Reverse for Gossamer Bio (GOSS)
    Nov 14 After Plunging -15.92% in 4 Weeks, Here's Why the Trend Might Reverse for Gossamer Bio (GOSS)
    Nov 12 Industry Analysts Just Made A Sizeable Upgrade To Their Gossamer Bio, Inc. (NASDAQ:GOSS) Revenue Forecasts
    Nov 10 Gossamer Bio, Inc. (NASDAQ:GOSS) Just Reported And Analysts Have Been Lifting Their Price Targets
    Nov 8 Gossamer Bio GAAP EPS of -$0.14, revenue of $9.48M
    Nov 7 Gossamer Bio (GOSS) Reports Q3 Loss, Tops Revenue Estimates
    Nov 7 Gossamer Bio: Q3 Earnings Snapshot
    Nov 7 Gossamer Bio Announces Third Quarter 2024 Financial Results and Provides Business Update
    Oct 31 NRx Pharmaceuticals added to Emerging Growth Conference 76 on October 31 and Update to Schedule
    Oct 30 Presenting on the Emerging Growth Conference 76 Day 2 on October 31 Register Now
    See more GOSS news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 1.6
    52 Week Low 0.4993
    Average Volume 884,219
    200-Day Moving Average 0.94
    50-Day Moving Average 0.92
    20-Day Moving Average 0.85
    10-Day Moving Average 0.79
    Average True Range 0.05
    RSI (14) 19.35
    ADX 39.46
    +DI 6.03
    -DI 31.32
    Chandelier Exit (Long, 3 ATRs) 0.80
    Chandelier Exit (Short, 3 ATRs) 0.84
    Upper Bollinger Bands 0.99
    Lower Bollinger Band 0.70
    Percent B (%b) -0.01
    BandWidth 34.53
    MACD Line -0.06
    MACD Signal Line -0.04
    MACD Histogram -0.017
    Fundamentals Value
    Market Cap 157 Million
    Num Shares 225 Million
    EPS -1.60
    Price-to-Earnings (P/E) Ratio -0.44
    Price-to-Sales 0.00
    Price-to-Book 1.87
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.76
    Resistance 3 (R3) 0.76 0.74 0.75
    Resistance 2 (R2) 0.74 0.72 0.74 0.74
    Resistance 1 (R1) 0.72 0.71 0.71 0.72 0.74
    Pivot Point 0.70 0.70 0.69 0.70 0.70
    Support 1 (S1) 0.68 0.68 0.67 0.68 0.65
    Support 2 (S2) 0.66 0.67 0.66 0.65
    Support 3 (S3) 0.64 0.66 0.65
    Support 4 (S4) 0.64